Rolke James 4
4 · REVELATION BIOSCIENCES, INC. · Filed Jan 12, 2026
Insider Transaction Report
Form 4
Rolke James
DirectorChief Executive Officer
Transactions
- Award
Common Stock
[F1]2026-01-08$0.90/sh+532,829$479,546→ 933,489 total
Holdings
- 400,660
Common Stock
Footnotes (1)
- [F1]Restricted Stock Units under the 2021 Equity Incentive Plan. Vests quarterly over two years from the date of grant.
Signature
/s/ J.P. Galda, as attorney-in-fact for James Rolke|2026-01-12